DE69928275D1 - Verfahren zur bestimmung der prognose für hiv-infizierte individuen - Google Patents

Verfahren zur bestimmung der prognose für hiv-infizierte individuen

Info

Publication number
DE69928275D1
DE69928275D1 DE69928275T DE69928275T DE69928275D1 DE 69928275 D1 DE69928275 D1 DE 69928275D1 DE 69928275 T DE69928275 T DE 69928275T DE 69928275 T DE69928275 T DE 69928275T DE 69928275 D1 DE69928275 D1 DE 69928275D1
Authority
DE
Germany
Prior art keywords
hiv
tat
infected individuals
hiv infected
determining prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69928275T
Other languages
English (en)
Other versions
DE69928275T2 (de
Inventor
Daniel Zagury
Jean-Francois Zagury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69928275D1 publication Critical patent/DE69928275D1/de
Application granted granted Critical
Publication of DE69928275T2 publication Critical patent/DE69928275T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69928275T 1998-08-21 1999-08-20 Verfahren zur bestimmung der prognose für hiv-infizierte individuen Expired - Lifetime DE69928275T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9749798P 1998-08-21 1998-08-21
US97497P 1998-08-21
PCT/US1999/018770 WO2000011225A1 (en) 1998-08-21 1999-08-20 Method for determining prognosis of hiv infected individuals

Publications (2)

Publication Number Publication Date
DE69928275D1 true DE69928275D1 (de) 2005-12-15
DE69928275T2 DE69928275T2 (de) 2006-07-20

Family

ID=22263678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928275T Expired - Lifetime DE69928275T2 (de) 1998-08-21 1999-08-20 Verfahren zur bestimmung der prognose für hiv-infizierte individuen

Country Status (7)

Country Link
EP (1) EP1123419B1 (de)
AT (1) ATE309394T1 (de)
CY (1) CY1106067T1 (de)
DE (1) DE69928275T2 (de)
DK (1) DK1123419T3 (de)
ES (1) ES2252971T3 (de)
WO (1) WO2000011225A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006088739A1 (en) * 2005-02-15 2006-08-24 Thymon, L.L.C. Assays for detecting the tat protein in hiv-1 infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
US5108891A (en) * 1988-06-09 1992-04-28 Beth Israel Medical Center Aids assay
DE19514089C2 (de) * 1995-04-13 1997-07-10 Deutsches Krebsforsch Nachweisverfahren für HIV-TAT

Also Published As

Publication number Publication date
ATE309394T1 (de) 2005-11-15
ES2252971T3 (es) 2006-05-16
WO2000011225A9 (en) 2000-08-17
EP1123419A1 (de) 2001-08-16
WO2000011225A1 (en) 2000-03-02
EP1123419B1 (de) 2005-11-09
EP1123419A4 (de) 2003-03-26
DE69928275T2 (de) 2006-07-20
CY1106067T1 (el) 2011-06-08
DK1123419T3 (da) 2006-03-27

Similar Documents

Publication Publication Date Title
ATE406578T1 (de) Candida-nachweis
PL367679A1 (en) A soluble complex comprising a retroviral surface glycoprotein
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ES8705522A1 (es) Un procedimiento para la preparacion de derivados purificados de una glicoproteina.
FI902143A0 (fi) Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.
ATE398276T1 (de) Verfahren und vorrichtung zur bestimmung einer route mit orten von interesse
DE69130396T2 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
ATE228248T1 (de) Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern
BR0114046A (pt) Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv
ATE309394T1 (de) Verfahren zur bestimmung der prognose für hiv- infizierte individuen
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
DK0991945T3 (da) Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum
DE69621837T2 (de) Methoden zur feststellung von alzheimerscher krankheit
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
CA2419046A1 (en) Method for detecting or measuring hbv
ATE292800T1 (de) Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
ES2140821T3 (es) Deteccion de la produccion de anticuerpos.
FI980863A0 (fi) Foerfarande foer bestaemning av en drycks oeverskumningsfaktor
ATE391914T1 (de) Assay
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
DE60231632D1 (de) Nachweis des rinderdiarrhoevirus in haarproben
ATE280949T1 (de) Verfahren zur bestimmung der avidität von antikörpern
WO2001044299A3 (de) Antikörper und verfahren zu ihrer herstellung, deren verwendung, sowie immunisierungscocktails, immunoassay-sets und peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition